Understanding the Meningococcal Vaccine

As the name of the vaccine would suggest, the Meningococcal Vaccine protects against Meningococcal disease. But, what is Meningococcal disease and why is getting the vaccine so important? With so many other vaccines to keep up with—such as COVID, the flu, or RSV—you might wonder if the Meningococcal Vaccine is important and if you fall into a risk category of people who are recommended to get it. Keep reading to learn more about Meningococcal disease, why getting the vaccine is important, and how you can get compensated for your timeand travel getting one in a Meningococcal Vaccine Clinical Study.

What is the Meningococcal Vaccine?

Meningococcal vaccines help protect against meningococcal disease. Meningococcal disease is a name for any infection caused by bacteria called Neisseria meningitidis. It is serious and can be deadly in hours. Early diagnosis and antibiotic treatment are important because people spread meningococcal bacteria through close or lengthy contact with other people. Anyone can get meningococcal disease, but certain people are at increased risk, making vaccines the best protection against meningococcal disease.

Even with antibiotic treatment, 10 to 15 in 100 people with meningococcal disease will die.

One in 5 survivors will have long-term disabilities, such as:

• Brain damage
• Deafness
• Loss of limb(s)

Who Should Get The Meningococcal Vaccine?

Anyone can get Meningococcal disease; however, the CDC recommends meningococcal vaccination for:

• All preteens and teens
• Children 2 months through 10 years old at increased risk
• Adults 19 years and older at increased risk

This disease is primarily spread through close, lengthy contact, such as kissing or living together

Not sure if you should receive the vaccine or not, but want to be protected from Meningococcal disease? Give our clinic a call at (682) 452-6276 so that we can pre-qualify you quickly and easily over the phone.

Meningococcal Vaccine Clinical Study

Protecting yourself against Meningococcal disease with the Meningococcal vaccine is the best way to combat this deadly, scary, unpredictable disease. If you are interested in getting the vaccine, Infectious Disease Clinical Trials will compensate you for your time and travel if you take part in our Meningococcal Vaccine Clinical Study.

In this study, you will be given the newest, latest, most cutting-edge, investigational Meningococcal vaccine available. To qualify as a participant in the study, all you have to do is give us a call at (682) 452-6276 to pre-qualify over the phone. We will then request to meet with you in person to finalize your participation in the study. Study participants are the most important aspect of any clinical study, which is why we made this process so simple and easy.

All studies conducted by our clinic are overseen by a central ethics committee, adhere to FDA regulations, are HIPAA compliant, and offer guaranteed confidentiality. Our team includes experienced professionals specializing in infectious diseases and vaccine development.

For more information or to see a list of other vaccine clinical trials that we are currently enrolling participants for, visit us at InfectiousDiseaseClinicalTrials.com!